Valeant Pharmaceuticals International, Inc.·4/A

May 8, 4:38 PM ET

POWER ROBERT N 4/A

4/A · Valeant Pharmaceuticals International, Inc. · Filed May 8, 2018

Insider Transaction Report

Form 4/AAmended
Period: 2018-05-03
Transactions
  • Award

    Common Stock, No Par Value

    2018-05-03+13,88172,109 total
Footnotes (2)
  • [F1]Represents the award of restricted share units ("RSUs") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. ("Valeant") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant.
  • [F2]This Amended Form 4 is being filed to correct the number of RSUs acquired on May 3, 2018 as reported on the Form 4 filed on May 4, 2018.

Documents

2 files
  • 4
    form4a.xml

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY- POWER